Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-02

Clinical Trial Update: Multicentric Randomised Trial for Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

This entry reports a multicenter randomized Phase 2 trial for resectable gastric cancer, sponsored by The Netherlands Cancer Institute, currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Gastric Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING